Financial Performance - The company's operating revenue for Q1 2024 was ¥110,910,882.85, representing a decrease of 11.32% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥4,280,819.84, down 69.36% year-on-year[5]. - The net profit after deducting non-recurring gains and losses was ¥2,389,180.90, a decline of 82.91% compared to the previous year[5]. - The total profit for Q1 2024 was CNY 4,964,641.05, down 68.5% from CNY 15,782,327.60 in Q1 2023[32]. - Operating profit for Q1 2024 was CNY 4,783,775.61, a decline of 71.0% from CNY 16,541,361.24 in the previous year[31]. - Basic earnings per share were ¥0.0811, down 77.01% compared to the same period last year[5]. - Basic and diluted earnings per share for Q1 2024 were CNY 0.0811, down from CNY 0.3528 in the same quarter last year[33]. Cash Flow - The net cash flow from operating activities was -¥33,083,910.65, reflecting a decrease of 52.40% year-on-year[5]. - The company experienced a net cash outflow from operating activities of CNY -33,083,910.65, compared to CNY -21,708,020.55 in Q1 2023[37]. - Cash flow from investment activities was -164.51 million RMB, with an increase in cash recovered from maturing financial products[11]. - Cash flow from investment activities showed a net inflow of CNY 320,154,489.21, a significant improvement from a net outflow of CNY -496,315,576.34 in the same quarter last year[37]. - The company's cash and cash equivalents as of March 31, 2024, were CNY 508,484,302.21, significantly up from CNY 177,209,198.06 at the end of 2023[24]. - The company’s cash and cash equivalents at the end of Q1 2024 totaled CNY 508,484,302.21, up from CNY 344,416,013.99 at the end of Q1 2023[38]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,380,282,591.02, an increase of 1.79% from the end of the previous year[5]. - Total current assets increased to CNY 805,079,264.50 from CNY 787,333,143.87, reflecting a growth of 2.23%[25]. - The total assets of the company reached CNY 1,380,282,591.02, an increase from CNY 1,356,033,826.42 at the end of 2023[29]. - Current liabilities rose to CNY 168,165,715.36 from CNY 148,669,680.70, marking an increase of 13.09%[27]. - The company's total equity attributable to shareholders was CNY 1,196,509,728.42, up from CNY 1,190,955,221.90[29]. Expenses - Research and development expenses totaled ¥17,523,425.37, accounting for 15.80% of operating revenue, an increase of 2.42 percentage points year-on-year[5]. - Period expenses increased by 12.46% year-over-year, totaling 48.36 million RMB[20]. - Sales expenses increased by 18.41% year-over-year, primarily due to hiring experienced sales personnel and increased overseas business activities[22]. - Management expenses rose by 17.11% compared to the previous year, driven by the recruitment of experienced management personnel and increased depreciation costs[22]. - R&D expenses increased by 4.75% as the company focused on innovation and expanding its R&D team to maintain competitiveness[22]. - The company reported a decrease in financial expenses, showing a net income of CNY -472,845.28 in Q1 2024, compared to CNY 1,557,280.18 in Q1 2023[31]. Sector Performance - The semiconductor sector accounted for 51.23% of total revenue, while the life sciences sector contributed 19.73%[20]. - The company is currently developing new products for the life sciences sector due to decreased demand from major clients[21]. - The company is facing challenges in the AR/VR testing sector as clients have adjusted their project directions, leading to reduced demand for testing equipment[21]. Other Notable Changes - The company reported a significant increase in cash received from tax refunds, up 495.72% due to increased tax refunds from overseas subsidiaries[10]. - The company experienced a 100% decrease in other operating expenses compared to the previous year, as there were no large donations this period[10]. - The gross margin was 49.48%, down 2.19% year-over-year[20].
茂莱光学(688502) - 2024 Q1 - 季度财报